penconazole has been researched along with Degenerative Diseases, Central Nervous System in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Dulmani, SA; Al-Zahrani, FAM; Galal, MK; Hassanen, EI; Hussien, AM; Ibrahim, MA; Kamel, S; Morgan, AM; Ogaly, HA; Rashad, MM | 1 |
1 other study(ies) available for penconazole and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
The ameliorative effect of N-acetylcysteine against penconazole induced neurodegenerative and neuroinflammatory disorders in rats.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Brain; Caspase 3; Elevated Plus Maze Test; Male; Malondialdehyde; Neurodegenerative Diseases; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Treatment Outcome; Triazoles | 2021 |